Group 1: single blood drawing

2 trials

Sponsors

Heidelberg ImmunoTherapeutics GmbH

Conditions

U07.1

Unknown Phase

Evaluation of SARS-CoV2-specific serum parameters in blood samples of SARS-CoV2-seronegative healthy volunteers, hospitalized SARS-CoV2-patients with acute disease and recovered SARS-CoV2-patients with asymptomatic/mild/severe disease.

Active, not recruitingDRKS00023877

Heidelberg ImmunoTherapeutics GmbHU07.1

Start: 2021-04-15Target: 150Updated: 2025-04-07

Evaluation of SARS-CoV2-specific serum parameters in blood samples of hospitalized COVID-19 patients with acute disease and recovered COVID-19 patients with asymptomatic disease (HTXCOV-01K)

Active, not recruitingDRKS00028158

Heidelberg ImmunoTherapeutics GmbHU07.1

Start: 2021-11-08Target: 20Updated: 2025-04-07